| Old Articles: <Older 15891-15900 Newer> |
 |
The Motley Fool July 31, 2006 Stephen D. Simpson |
Brush Engineered: Special Materials, Special Results Despite the volatility in the shares, these are still pretty good days for specialty metal companies. Investors, if you are willing to tolerate some sever ups and downs along the way, a position in this company could be rewarding.  |
The Motley Fool July 31, 2006 Rick Aristotle Munarriz |
4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious. Here's a closer look at four of the companies that inched their payouts higher this past week: Time Warner... Station Casinos... Gannett... Boyd Gaming...  |
The Motley Fool July 31, 2006 Anders Bylund |
3 Stocks That Missed the Mark A peek at companies that over-promised and under-delivered. Norfolk Southern... Peru Copper... Florida Rock...  |
The Motley Fool July 31, 2006 Anders Bylund |
PortalPlayer Making a Comeback After losing its best customer, the small chip designer is regrouping into other areas. Investors, take note.  |
The Motley Fool July 31, 2006 Anders Bylund |
TECO Powers Up Despite tough conditions, this local power company comes out ahead. Investors, take note.  |
The Motley Fool July 31, 2006 Anders Bylund |
Foolish Forecast: Otter Tail Power The regional power company is set to report earnings tonight. Here is information to help investors get a handle on what to expect.  |
BusinessWeek August 7, 2006 Gene G. Marcial |
Bullish On Bear Stearns Volatility is a broker's friend, and the market's recent swings have produced outsize gains for some of the biggest brokerages.  |
BusinessWeek August 7, 2006 Gene G. Marcial |
Bally: Better Grades After It Does The Homework? Bally Technologies has plenty going for it as the second-largest maker of slot and lottery machines, but a huge thorn is poking the stock.  |
BusinessWeek August 7, 2006 Gene G. Marcial |
Emisphere Dances With Giants Tiny biotech Emisphere Technologies has attracted Big Pharma to team up on its products still in clinical trials.  |
Chemistry World July 28, 2006 Katharine Sanderson |
Dow Chemical Takes a Dive America's largest chemical manufacturer, has blamed unrelenting raw material and energy price rises for its disastrous second quarter performance: the company's net income fell by 19% and share prices tumbled.  |
| <Older 15891-15900 Newer> Return to current articles. |